Skip to main content

Tweets

Lung Cancer in Rheumatoid Arthritis and Interstitial Lung Disease A matched cohort study from the Veterans Health Administration shows that RA patients have a >50% increased risk of lung cancer, a 3-fold higher risk of lung cancer in RA-ILD. https://t.co/J9FCdkId8H https://t.co/uJylDP3IIp
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Romosozumab vs. Teriparatide in Postmenopausal Osteoporosis The effectiveness/safety of ROMO and TPTD were compared in a clinical setting, and ROMO showed greater increases in BMD than TPTD after 12 months of therapy, along with a higher completion rate. https://t.co/iKKLruiiay https://t.co/vPKa8pom7e
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Anti-Inflammatory Diet yields a lower risk of Dementia. UK Biobank study shows patients w/ type 2 diabetes, heart disease, or stroke who were on an anti-inflammatory diet had a 31% lower risk for dementia vs. a pro-inflammatory diet https://t.co/OjHq3BBOfd https://t.co/tG9vO59IEc
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Hispanic Patients With Dermatomyositis JAMA Dermatology has published a review of dermatomyositis (DM), focusing on similar and different manifestations of DM. https://t.co/HydzbzTJR4 https://t.co/KJs681ySO7
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Less Mortality with GLP-1 Agonists in Rheumatic Patients A recent study in PLOS ONE found that treating type 2 diabetes with GLP-1-RAs lowered the risk of mortality and cardiovascular events in patients with IMIDs and type 2 diabetes. https://t.co/MzCG7WvrDS https://t.co/0RPIfOO0s7
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Rheums! Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/GV6WjsqZBH https://t.co/9l9qyJpg3I
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Among the 1st 10 drug prices Negotiated by Medicare - Two are for Rheums: - Etanercept; original price $7,106/Mo], negotiated price $2,355 (67% decr) - Ustekinumab: for original price $13,836/mo, negotiated price $4,695 (66% decr) https://t.co/eexr4Acrbi https://t.co/fE0aoD8vA3
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
More Noninflammatory Pain in Difficult to Treat RA A Canadian cohort of difficult-to-treat rheumatoid arthritis (D2T RA) patients shows significantly more non-inflammatory pain in D2T RA compared to patients responding to b/tsDMARDs. https://t.co/XRH9q0gNyq

Dr. John Cush @RheumNow ( View Tweet )

1 year 5 months ago
355 PsA (n=279) & psoriasis (76) pts studied. PsA pts had more comorbidity vs PsO (43% v 26%). >70% low exercise level. Exercise signif improved DAPSA, TJC/SJC, ESR, PASI. Hi Mediterranean diet decr ESR, PASI, but signif only for enthesitis (p 0.015) https://t.co/mdruLj9h5a https://t.co/NOiwXju0wm
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
The Burden of Rheumatoid Arthritis (2018–2020) A recent study that quantified the economic and humanistic burden of RA in the US showed significantly higher health care expenditures, particularly medication costs, and suboptimal quality of life in RA. https://t.co/1v3CDtZC0l https://t.co/WPWuOvpkfa
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Depends on Where You’re Looking (8.9.2024) https://t.co/GDAN37DJSx https://t.co/jVoumC00r5
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
Mass General Brigham Study 172 RA-ILD pts w/ 6.5 yrs F/U (age 62 yrs): noted (4%) lung transplants & 44 (26%) ILD-related deaths. FVC rapidly declining pts (14%) had aOR 19x lung transplant & aOR 2.8 ILD-related death. Slow decline in 54%, no decline 32% https://t.co/fKDnJIu9a7 https://t.co/ondzN4WZ1F
Dr. John Cush @RheumNow ( View Tweet )
1 year 5 months ago
×